These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21275998)

  • 1. In vivo viability of stored red blood cells derived from riboflavin plus ultraviolet light-treated whole blood.
    Cancelas JA; Rugg N; Fletcher D; Pratt PG; Worsham DN; Dunn SK; Marschner S; Reddy HL; Goodrich RP
    Transfusion; 2011 Jul; 51(7):1460-8. PubMed ID: 21275998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Red blood cells derived from whole blood treated with riboflavin and ultraviolet light maintain adequate survival in vivo after 21 days of storage.
    Cancelas JA; Slichter SJ; Rugg N; Pratt PG; Nestheide S; Corson J; Pellham E; Huntington M; Goodrich RP
    Transfusion; 2017 May; 57(5):1218-1225. PubMed ID: 28369971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of potential immune response and in vivo survival of riboflavin-ultraviolet light-treated red blood cells in baboons.
    Goodrich RP; Murthy KK; Doane SK; Fitzpatrick CN; Morrow LS; Arndt PA; Reddy HL; Buytaert-Hoefen KA; Garratty G
    Transfusion; 2009 Jan; 49(1):64-74. PubMed ID: 18954398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C.
    Bihm DJ; Ettinger A; Buytaert-Hoefen KA; Hendrix BK; Maldonado-Codina G; Rock G; Giclas PC; Goodrich RP
    Vox Sang; 2010 Feb; 98(2):108-15. PubMed ID: 19719460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein stability of previously frozen plasma, riboflavin and UV light-treated, refrozen and stored for up to 2 years at -30 °C.
    Ettinger A; Miklauz MM; Hendrix BK; Bihm DJ; Maldonado-Codina G; Goodrich RP
    Transfus Apher Sci; 2011 Feb; 44(1):25-31. PubMed ID: 21251884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma.
    Smith J; Rock G
    Transfusion; 2010 Apr; 50(4):926-31. PubMed ID: 20051060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riboflavin-ultraviolet light pathogen reduction treatment does not impact the immunogenicity of murine red blood cells.
    Tormey CA; Santhanakrishnan M; Smith NH; Liu J; Marschner S; Goodrich RP; Hendrickson JE
    Transfusion; 2016 Apr; 56(4):863-72. PubMed ID: 26643781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogen inactivation by riboflavin and ultraviolet light illumination accelerates the red blood cell storage lesion and promotes eryptosis.
    Qadri SM; Chen D; Schubert P; Perruzza DL; Bhakta V; Devine DV; Sheffield WP
    Transfusion; 2017 Mar; 57(3):661-673. PubMed ID: 28019031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation.
    Reddy HL; Dayan AD; Cavagnaro J; Gad S; Li J; Goodrich RP
    Transfus Med Rev; 2008 Apr; 22(2):133-53. PubMed ID: 18353253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogen reduction of fresh plasma using riboflavin and ultraviolet light: effects on plasma coagulation proteins.
    Hornsey VS; Drummond O; Morrison A; McMillan L; MacGregor IR; Prowse CV
    Transfusion; 2009 Oct; 49(10):2167-72. PubMed ID: 19555414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction.
    AuBuchon JP; Herschel L; Roger J; Taylor H; Whitley P; Li J; Edrich R; Goodrich RP
    Transfusion; 2005 Aug; 45(8):1335-41. PubMed ID: 16078923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved in vitro quality of stored red blood cells upon oxygen reduction prior to riboflavin/UV light treatment of whole blood.
    Schubert P; Culibrk B; Chen D; Serrano K; Levin E; Chen Z; Zoescher P; Goodrich RP; Yoshida T; Devine DV
    Transfusion; 2019 Oct; 59(10):3197-3204. PubMed ID: 31408208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro quality of single-donor platelets treated with riboflavin and ultraviolet light and stored in platelet storage medium for up to 8 days.
    Cookson P; Thomas S; Marschner S; Goodrich R; Cardigan R
    Transfusion; 2012 May; 52(5):983-94. PubMed ID: 22014032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White blood cell inactivation after treatment with riboflavin and ultraviolet light.
    Marschner S; Fast LD; Baldwin WM; Slichter SJ; Goodrich RP
    Transfusion; 2010 Nov; 50(11):2489-98. PubMed ID: 20529002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products.
    Goodrich RP; Doane S; Reddy HL
    Biologicals; 2010 Jan; 38(1):20-30. PubMed ID: 20093041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method.
    Schubert P; Culibrk B; Karwal S; Serrano K; Levin E; Bu D; Bhakta V; Sheffield WP; Goodrich RP; Devine DV
    Transfusion; 2015 Apr; 55(4):815-23. PubMed ID: 25355434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pre-freeze pathogen reduction with riboflavin and UV light on red cells stored post-thaw in AS-3 additive solution.
    Kutac D; Bohonek M; Landova L; Staskova E; Blahutova M; Lovecky J; Horacek JM; Stansbury LG; Hess JR
    Transfusion; 2023 May; 63(5):1067-1073. PubMed ID: 36938976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of antibody formation to platelet neoantigens after transfusion of riboflavin and ultraviolet light-treated platelet concentrates.
    Ambruso DR; Thurman G; Marschner S; Goodrich RP
    Transfusion; 2009 Dec; 49(12):2631-6. PubMed ID: 19694996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell quality of apheresis-derived platelets treated with riboflavin-ultraviolet light after resuspension in platelet additive solution.
    Picker SM; Tauszig ME; Gathof BS
    Transfusion; 2012 Mar; 52(3):510-6. PubMed ID: 21981030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell viability during platelet storage in correlation to cellular metabolism after different pathogen reduction technologies.
    Picker SM; Schneider V; Oustianskaia L; Gathof BS
    Transfusion; 2009 Nov; 49(11):2311-8. PubMed ID: 19624608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.